Resources

Filter:

Read more

Agepha Pharma partners with Caristo Diagnostics

Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

Press Release Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®– colchicine, 0.5 mg…

Read more

AHA Late Breaking Science Presentation

American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI

Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…

Read more

World Heart Day Programme by British Heart Foundation

British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day

Press Release British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day CaRi-Heart®…

Read more

BREAKING BOUNDARIES: 15 HEALTH CARE STARTUPS IN OXFORDSHIRE TAKING THE WORLD BY STORM

The health care startup scene in Oxford, Oxfordshire, United Kingdom, is thriving with innovative companies that are making a significant…

Read more

Article in magazine on caristo

New Cardiac Disease Diagnostic Technology Piloting in the UK

The new pilot supported by NHS England will involve five NHS trusts, including University Hospitals of Leicester NHS Trust, Liverpool…

Read more

Caristo Diagnostics Piloting New Cardiac Disease Diagnostic Technology in UK NHS Hospitals

Press Release Latest CaRi-Heart® Technology Raises the Bar for CAD Management by Quantifying Both Coronary Inflammation and Plaque Caristo Diagnostics…

Read more

odoco_colchicine_tablets_agepha_pharma_

Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular Disease

Colchicine’s Approval Heightens the Need for Technologies Detecting Inflammation Specifically Related to Coronary Arteries OXFORD, England, June 22, 2023 — Caristo Diagnostics…

Read more

Quote by Frank Cheng, CEO, Caristo Diagnostics

CEO Spotlight: Frank Cheng, Caristo Diagnostics

Caristo’s Frank Cheng speaks with OUI on transforming heart disease diagnostics, the evolution of Oxford, and the future of one…


View Resources Archive

Get in touch for more information.